Birchview Capital, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $108 Million distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $35.5M, Biodesix Inc with a value of $9.86M, Acadia Pharmaceuticals Inc with a value of $6.16M, United Therapeutics Corp with a value of $3.58M, and Prothena Corp Public LTD CO with a value of $3.51M.

Examining the 13F form we can see an increase of $8.32M in the current position value, from $100M to 108M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $108 Million
Healthcare: $105 Million
Energy: $3.27 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $108 Million
  • Prior Value $100 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.